[Clinical and x-ray features of lung lesions in influenza uncomplicated and complicated by pneumonia].

Clinical and X-ray features of pulmonary lesions were studied in 858 inpatients with pneumonia-complicated and uncomplicated influenza. This showed it possible to establish a clinical and X-ray diagnosis of viral pulmonary lesions in the early period of infection. There was a correlation between influenza toxicosis and the magnitude of lung X-ray changes.

[Photochemotherapy in the treatment of acute pneumonias].

The application of photochemotherapy in acute pneumonia is based on pneumonia pathogenesis and the mechanism of ALIB- (autotransfusion of laser irradiated blood) and AUVBI- (autotransfusion of ultraviolet blood irradiation) techniques. The ALIB is preferable since the technique requires no device sterilization. The complex treatment of acute pneumonia with ALIB and AUVBI was found to enhance therapeutic efficacy, to decrease the severity of the disease course, to reduce its duration and hospital stay in inpatients.

[Mortality and lethality of influenza and acute respiratory diseases].

Analysis of mortality and lethality rates due to influenza, acute respiratory disease (ARD), and acute pneumonia in adults has revealed a higher proportion in an old-age group (over 60 years) than in younger-age ones (15-30-year olds). Moreover, these figures have been found to have increased twice in the old-age group in the last two decades. At the same time the lethality rates due to acute pneumonia have been reported to be 8-12 times higher in inpatients over 60 years of age (a high-risk group) than those in younger adults and 3-4 times higher than those in the middle-age group.

[Current approaches to the treatment of severe influenza].

The complex pathogenetic therapy of severe (complicated) forms of influenza infection is proposed. The drugs with antioxidant, antiprotease or immunomodulating activities are used for the purpose. The clinical character of infection or stage of pathologic process are considered for appropriate drug application.